{"id":2936,"date":"2018-02-16T18:05:39","date_gmt":"2018-02-16T18:05:39","guid":{"rendered":"http:\/\/www.sarmsthailand.com\/?post_type=product&p=2936"},"modified":"2026-07-24T04:58:21","modified_gmt":"2026-07-24T04:58:21","slug":"ligandrol","status":"publish","type":"product","link":"https:\/\/www.sarmsthailand.com\/th\/product\/ligandrol\/","title":{"rendered":"LGD-4033 (Ligandrol) 10 mg\/ml (30ml)"},"content":{"rendered":"
\n

Buy LGD-4033 Ligandrol in Thailand<\/h2>\n

LGD-4033 Ligandrol comes in a 30ml liquid bottle containing 10 mg per ml. LGD-4033 is also known as Ligandrol and VK5211.<\/p>\n

LGD-4033 is a nonsteroidal selective androgen receptor modulator, commonly abbreviated as a SARM. It has been investigated for conditions involving muscle loss and reduced physical function, but it has not been approved as a medicine.<\/p>\n

\n

LGD-4033 Product Specifications<\/h2>\n
\n\n\n\n\n\n\n\n\n
Product<\/th>\nLGD-4033 Ligandrol<\/td>\n<\/tr>\n
Other name<\/th>\nVK5211<\/td>\n<\/tr>\n
Concentration<\/th>\n10 mg per ml<\/td>\n<\/tr>\n
Bottle size<\/th>\n30ml<\/td>\n<\/tr>\n
Format<\/th>\nLiquid<\/td>\n<\/tr>\n
Compound class<\/th>\nInvestigational selective androgen receptor modulator<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n

What Is LGD-4033?<\/h2>\n

LGD-4033 was developed to interact selectively with androgen receptors in tissues such as muscle and bone. The objective behind this area of research was to investigate whether some anabolic effects could be separated from the broader effects associated with traditional androgenic compounds.<\/p>\n

Although LGD-4033 is commonly promoted online for muscle growth and strength, its investigational status means that retail claims should not be treated as proven medical benefits or predictable individual outcomes.<\/p>\n

Human Research on LGD-4033<\/h2>\n

A placebo-controlled study evaluated LGD-4033 in 76 healthy men between 21 and 50 years old. Participants received a placebo or one of three LGD-4033 amounts daily for 21 days.<\/p>\n

The study reported dose-related increases in lean body mass during the three-week research period. LGD-4033 was also described by the researchers as having a favorable pharmacokinetic profile, with no serious adverse events reported during the study.<\/p>\n

The research helped establish LGD-4033 as one of the better-known investigational SARMs and contributed to continued interest in its potential effects on muscle and physical function.<\/p>\n

Research Status and Limitations<\/h2>\n

LGD-4033 remains an investigational compound rather than an approved medicine. The available controlled human study was short and cannot establish the results or safety of longer-term use. Individual outcomes may differ, and published research should not be treated as a guarantee of a particular result.<\/p>\n

LGD-4033 and Tested Sport<\/h2>\n

LGD-4033, also identified as Ligandrol, is prohibited under the World Anti-Doping Agency Prohibited List. Athletes subject to anti-doping testing should avoid exposure to this compound.<\/p>\n

Independent Information Sources<\/h2>\n